版本:
中国

BRIEF-Yield10 Bioscience Q4 loss per share $0.06 from continuing operations

March 22 Yield10 Bioscience Inc

* Q4 revenue $341,000 versus $100,000

* Yield10 Bioscience announces fourth quarter and full year 2016 financial results

* Q4 loss per share $0.06 from continuing operations

* Company anticipates that it will need approximately $7.5 million to $8.0 million of cash during 2017

* Yield10 bioscience-co's ability to continue operations after current cash resources are exhausted depends on ability to obtain additional financing Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐